Risk of prostatitis in patients with type 2 diabetes mellitus: An observational retrospective cohort study of canagliflozin versus other antihyperglycemic agents using propensity score matching
Fig 3
Crude on-treatment incidence rate (per 1000 PYs) of prostatitis for each treatment cohort by database.
CDM, Clinformatics® Data Mart; CCAE, commercial claims and encounters; EHR, electronic health record; EMR, electronic medical record; MDC, medical data center; MDCD, multi-state Medicaid database; MDCR, Medicare supplemental; PY, person-year.